Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis

NCT02854943 is registered in ClinicalTrials.gov with Gunnar Lachmann as lead sponsor.

NCT NCT02854943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02854943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis
Lead sponsor
Gunnar Lachmann
Phase
Observational
Overall status
Completed
Start date
January 31, 2000
Completion date
August 31, 2018
Enrollment
2,623 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophagocytic lymphohistiocytosis (hlh), hemophagocytic syndromes, macrophage activation syndrome (mas)